Search Results 71-80 of 19639 for autoimmune hepatitis
Specialized treatment for patients with immune-mediated liver disease, such as primary biliary cirrhosis, autoimmune hepatitis and primary sclerosing ...
... hepatitis, and congestion associated with cardiac hepatopathy. ... liver disease. This will differentiate Mayo from ... liver disease (NAFLD), both common ...
The purpose of this study is to determine if Non-Alcoholic Fatty Liver Disease (NAFLD) patients with advanced fibrosis will demonstrate a change in PRO-C3, a ...
The purpose of this study is to compare the incidence and frequency of elevated liver enzymes or parenteral (IV) nutrition-associated liver disease, in adult ...
Liver Disease: A Paradigm for Understanding Environment-Epigenome Interaction ... Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death ...
The purpose of this study aims to investigate the efficacy and safety of survodutide administered once weekly vs. placebo on liver-related outcome events and ...
Hepatitis caused by a virus — including hepatitis A, B and C — or caused by infectious mononucleosis. Nonalcoholic fatty liver disease (NAFLD), now known as ...
The purpose of this study is to determine if extracellular (EV) counts and content can differentiate Alcoholic Hepatitis (AH) from alcoholic liver disease as ...
Mayo Clinic researchers have pinpointed how excessive alcohol consumption contributes to fatty liver disease, a condition that affects more than one in ...
experimental therapy to regenerate tissue in patients with late-stage liver disease. This new technology takes mesenchymal stem cells from adipose (fat) tissue ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.